---
title: A Hidden Molecule Stops Iron From Poisoning Our Cells
description: Researchers at MIT’s Whitehead Institute found that polyamines protect cells from toxic iron, a discovery with implications for cancer treatment and Parkinson’s disease.
author: Darie Nani (Editor-in-Chief)
updated: 2026-08-15T05:19:39.416Z
canonical: https://richhealthmagazine.com/article/polyamines-protect-cells-iron-overload-cancer
image: https://cdn.nanimediahouse.com/whitehead-polyamines-iron-154871.webp
categories: Longevity & Science
content_type: News
region: Global
publication: Rich Health Magazine
schema_type: Article
---

Every cell in the body depends on iron. It helps produce energy, carries oxygen, and drives countless chemical reactions that keep us alive. But iron is also dangerous. When it sits unbound and free inside a cell, it sets off destructive reactions that tear apart DNA, proteins, and even the membranes that hold a cell together. For decades, scientists have wondered what keeps that danger in check day to day. Researchers at the Whitehead Institute, a biomedical research institute affiliated with MIT, have now found an answer in a place nobody expected: polyamines, small molecules already known for a completely different job.

The team, led by Whitehead Institute member Ankur Jain, former postdoc Whitney Henry, and graduate student Pushkal Sharma, discovered that polyamines act like storage lockers for iron. They hold the metal in a safe, non-reactive state until the cell actually needs it, quietly preventing the kind of iron overload in cells that would otherwise cause damage. Jain and Henry are co-senior authors of the study, and Sharma is its first author. Their findings were published August 14 in the journal Cell, in a paper titled “Polyamines buffer labile iron to suppress ferroptosis.”

The discovery solves a puzzle that has sat unanswered for years. Polyamines are among the most abundant small molecules in our cells, present at levels that rival ATP, the molecule cells use as fuel. Their best-known role is helping cells grow and divide, but that job only accounts for a small fraction of the polyamines a cell actually carries. Nobody had a good explanation for why cells hold so much more than they seem to need. “We’ve known that without polyamines, cells stop growing and dividing,” Jain says. “But their best-known function only requires a small fraction of the polyamine levels cells actually have.” His lab came to the question sideways, through its usual work studying RNA, the molecule that helps translate genetic instructions into action. Polyamines bind RNA and help shape its structure, which is what first drew the researchers’ attention. Given how much of the molecule cells hold onto, they suspected there had to be more to the story.

## Losing Polyamines Makes One Protein Essential for Survival

To find out what that “more” was, the researchers ran a genome-wide CRISPR-Cas9 screen, a large-scale genetic test that checks every gene in human cells at once, on cells whose polyamine levels had been artificially lowered. They wanted to see which cellular processes broke down without polyamines around. The screen turned up a protein called GPX4. Normally, GPX4 is one option among several that a cell can use to prevent damage to the fatty molecules in its membranes, a process known as lipid peroxidation. But when polyamine levels dropped, GPX4 stopped being optional. Cells suddenly needed it to survive, or they died through ferroptosis, a form of cell death driven by that same iron-fueled membrane damage. The team also found that cells low on polyamines carry more of a separate protein that works like an iron sponge, locking the metal away in a mineralized form, a second sign that the cell was straining to contain iron it could no longer buffer.

## Cancer Cells Depend on Polyamines to Grow

Cancer cells often rely on high polyamine levels to fuel their rapid growth and division, which is why drugs that try to lower polyamine levels have long been explored as [cancer treatments](https://richhealthmagazine.com/article/light-made-a-cancer-drug-up-to-96-times-more-potent-in-the-lab), so far with only limited success. This new work suggests why that approach alone may fall short.

> "We saw that when polyamine levels fall, cells rely on GPX4 to protect themselves from iron toxicity. This could mean that combining drugs that lower polyamine levels with those that block GPX4 might be more effective for killing cancer cells than targeting either pathway alone."
> — Pushkal Sharma, the study’s first author

The findings also reach into neuroscience. Mutations in genes that shuttle polyamines around cells are linked to a rare, early-onset form of Parkinson’s disease, and scientists have long observed unusually high iron levels in the brains of people with Parkinson’s. Whether that excess iron actually contributes to [the death of neurons](https://richhealthmagazine.com/article/blood-test-which-neurons-dying-cfdna) in the disease is still unclear, but the new work offers a plausible explanation for the pattern, and a fresh direction for investigating it.

## A New Sensor Lets Scientists Watch Iron Rise in Real Time

To confirm that polyamines themselves were doing the buffering, the researchers made a genetically encoded fluorescent sensor that causes living cells to glow according to how much chemically reactive iron they contain, and paired it with an existing sensor for polyamine levels. Watching both under a microscope, they saw a tight, inverse relationship play out cell by cell: as polyamines fell, reactive iron rose. The paper concludes that the findings “reposition polyamines as key regulators of iron homeostasis, with implications for ferroptosis-linked disease states and cellular redox balance.”

The sensor the team developed to track reactive iron is expected to outlive this one study. Because it lets scientists watch iron behavior in living cells in real time, researchers studying aging, cancer, and neurodegeneration are likely to put it to use well beyond this project. As Jain puts it, “There are a lot of promising future directions for this work. It’s exciting to think about how these tools and findings could help answer further questions about disease pathways and potentially help design better therapies.”

The full study is described at the [Whitehead Institute](https://wi.mit.edu/news/cells-use-little-known-molecule-protect-themselves-iron-overload).

## FAQ

**Q: What is ferroptosis?**
Ferroptosis is a form of cell death driven by iron. When reactive, unbound iron builds up inside a cell, it damages the fatty molecules in the cell’s membranes, a process called lipid peroxidation, and that damage can kill the cell.

**Q: What are polyamines?**
Polyamines are small molecules found in huge quantities inside our cells, at levels comparable to ATP. They are best known for helping cells grow and divide, but the new study shows they also work as storage lockers that hold iron safely until it is needed.

**Q: What does GPX4 do?**
GPX4 is a protein that normally helps prevent lipid peroxidation, the membrane damage at the heart of ferroptosis. The study found that when polyamine levels drop, cells become dependent on GPX4 to avoid dying from iron toxicity.

**Q: Is ferroptosis good or bad in cancer?**
It depends on the context. Cancer cells often rely on high polyamine levels to grow quickly, and the researchers suggest that combining drugs that lower polyamines with drugs that block GPX4 could be a more effective way to trigger ferroptosis in cancer cells than either strategy alone.

**Q: Is there a link between iron and Parkinson’s disease?**
Mutations in genes that move polyamines around cells are linked to a rare, early-onset form of Parkinson’s, and elevated iron levels have long been seen in the brains of Parkinson’s patients. It remains unclear whether that iron directly causes neuron death, but the new discovery offers a possible explanation worth investigating further.